US OptionsDetailed Quotes
RIGL241220C12000
- 7.25
- 0.000.00%
15min DelayTrading Nov 8 10:36 ET
0.00High0.00Low
0.00Open7.25Pre Close0 Volume7 Open Interest12.00Strike Price0.00Turnover366.31%IV-0.31%PremiumDec 20, 2024Expiry Date7.31Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9214Delta0.0196Gamma2.54Leverage Ratio-0.1297Theta0.0011Rho2.34Eff Leverage0.0030Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet